Our Story

Aerogen, world leader in acute care aerosol drug delivery

From humble beginnings above the local butcher shop to world leader in acute care aerosol drug delivery

Aerogen is synonymous with the effective treatment of respiratory illness among patient groups of all ages playing a critical role in emergency departments and intensive care units in over 75 countries worldwide.

With a strong commitment to scientific excellence, Aerogen invests heavily in research and development to evolve its pioneering product range and change the future of respiratory patient care.



Cerus Medical founded by John Power


Merger of Cerus Medical with Aerogen Inc. & IPO on NASDAQ


Launch of the Aerogen Pro


Acquisition of Aerogen, Inc. by Nektar Therapeutics


Management buyout of Aerogen from Nektar


Aerogen win IMDA Excellence Award for the Aerogen Solo


Ernst & Young Entrepreneur of the Year Finalist


Aerogen Integrate their ground breaking technology with MAQUET ICU ventilators


Aerogen Approved for Chinese Market


IMDA Medical Technology Company of the Year Award and Aerogen reach over 1 million patients


Winners of the Irish Exporter of the Year


Winners of the AARC Zenith Award and Aerogen reach over 3 million patients worldwide


John Power named RSM European Entrepreneur of the Year. Zenith Award Recipients for 3rd time.


Winners of the AARC Zenith Award for the fourth time

Our Values

We take pride in the knowledge that every day, we are working for the greater good and well-being of respiratory patients worldwide.

The Aerogen brand values underpin everything that we do and reflect Aerogen’s commitment to developing better technology to deliver better patient outcomes.


We are global leaders in high performance aerosol drug delivery. We apply our intelligence & expertise to create breakthroughs in new science for the greater good of patient care.


We put patient’s needs at the heart of everything we do. It is our awareness and understanding of patient’s needs that allows us to take an holistic view of what’s required from Aerogen in the marketplace.


Our high performance ethos and dedication to the task in hand drives us to seek innovative solutions to complex problems that will ultimately deliver better patient care.

Our Awards


Medical Technology Company of the Year

Irish Medical Devices Association, IDA Ireland and Enterprise Ireland


Silver in IMDA Excellence

Irish Medical Devices Association


Finalist in Engineers Excellence Awards

Irish Engineering Awards


Aerogen values the humanitarian efforts of many Irish and international charities which is why the Aerogen team is proud to give back and support these deserving charities:

Foundation Nepal

An Irish charity helping the most vulnerable in highly disadvantaged Nepalese communities to work their way out of poverty.

World Vision Ireland

One of the leading humanitarian relief organisations dedicated to addressing the causes of global poverty.

Soul of Haiti

Works to empower communities to create their own success through relationships with a community of Irish entrepreneurs. Establishing enterprise links and facilitating trade and investment in Haiti is the focus of this charity.

Society of St. Vincent de Paul

The largest voluntary organisation in Ireland today working towards a more just, caring and equal society.


A dedicated heart & stroke centre with the aim of reducing the impact of heart disease & stroke on families in the West of Ireland

John Power, CEO Aerogen, European Entrepreneur of the Year 2015/16

A Serial Entrepreneur in a technology and innovation focused career spanning over 30 years, John has held executive level positions in R&D, Operations, Sales and General Management in both the SME and MNC environment. During this period he has been a founder or co-founder of several ‘Blue Ocean’ technology start-ups the last three of these in the life-science sector.

John has led Aerogen from start-up in 1997 through a US merger, subsequent NASDAQ IPO, acquisition and MBO in 2008. Today Aerogen is recognized as a pioneer in high performance nebulisation and a global leader in ICU ventilator / Hospital based aerosol drug delivery. Its award winning products are employed in over 75 countries throughout the world helping to provide life critical interventions from the emergency department through to the NICU. Aerogen’s proprietary technology permits proteins, peptides, suspensions and solutions to be nebulised paving the way for targeted drug delivery to the lung.

Since 2008 the company has grown revenues 30%+ year on year and in recognition of its export success Aerogen was awarded the prestigious European Business Award Ruban d’Honneur in 2011 and again in 2016, where John was also named the European Entrepreneur of the Year.  Aerogen was named the Irish Exporter of the Year 2014. In 2013, 2015 & 2016 Aerogen received the highest award granted by the American Association of Respiratory Care, the Zenith Award, for ‘providing products and services that enable respiratory care physicians and therapists to achieve clinical excellence’. Also in 2013 Aerogen was voted Irish Med-Tech Company of the year.

A Chartered Engineer, John is recognized as a technology innovator and is credited with over a dozen commercialized International patents in products ranging from robotics to life-support ventilation. He holds an MBA from Oxford Brookes University and as an Adjunct Lecturer at National University of Ireland Galway (NUIG), he guest lectures on his core business interests of Innovation Strategies and Technology Entrepreneurship.

He is a founder faculty member of the NUIG Bio-Innovate program (run in conjunction with Stanford University Bio-Design), an incubator unit that promotes entrepreneurial start-up’s in medical technologies where he has actively mentored several early stage companies. In 2016 in recognition of his contribution to the development of the Irish Medical Device sector John was conferred with an Honorary Doctorate by the National University of Ireland Galway.

John is a senior member of the Board of the Irish Medical Device Association where he has represented Ireland as an Industry expert in the European Competitive Council in Brussels. He previously served as a Board member of The Irish Research Council for Science, Engineering and Technology.

John is a very active social entrepreneur in both his community where he has been chairman and long-term member of his Community Development Association and Internationally through Foundation Nepal and World Vision where he has led significant fundraising initiatives for irrigation / agricultural and local enterprise development.


Board of Directors

Dr Bernard Collins Chairman

As Chairman of Aerogen’s board of directors, Dr Bernard Collins brings a wealth of business experience. He is Chairman of Vhi Healthcare and a board member of IDA Ireland. He serves on the Board of Directors of several U.S. and Irish life-science companies. Prior to forming Lifemed, his consultancy company, Dr Collins served for 10 years as Vice President of International Operations at Boston Scientific Corporation and before this held senior executive positions in life-science companies including Baxter Corporation. His general management experience in the medical device and health care industry spans start-ups, turnarounds, leveraged buyouts and IPOs for both large and small businesses.

Dr Jane E. Shaw (US) Chairperson Scientific Advisory Board

Dr Jane Shaw governs Aerogen’s scientific advisory board. She has been a director of Intel since 1993 and Chairman of the Board of Directors of Intel since May 2009. She is a Director and Board member of McKesson Corporation since 1992 where she is the Chair of the Committee on Directors and Corporate Governance and a member of the Audit Committee. In 2005 Dr Shaw retired as Chairman and CEO of Aerogen Inc. after serving as Chairman and CEO since 1998. Dr Shaw previously served as President and COO of ALZA Corporation, a pharmaceutical company, and was founder of The Stable Network, a biopharmaceutical consulting company. She is on the Board of several early stage life-science companies including Aerogen’s surgical drug delivery spin-out AeroSurgical.